company background image
FLRY3 logo

Fleury BOVESPA:FLRY3 Rapport sur les actions

Dernier prix

R$13.54

Capitalisation boursière

R$7.5b

7D

-3.0%

1Y

-20.6%

Mise à jour

18 Nov, 2024

Données

Finances de l'entreprise +

Fleury S.A.

BOVESPA:FLRY3 Rapport sur les actions

Capitalisation boursière : R$7.5b

FLRY3 Aperçu des actions

Fleury S.A., avec ses filiales, fournit des services médicaux dans les domaines du diagnostic, du traitement, de l'analyse clinique, de la gestion de la santé, des soins médicaux, de l'orthopédie et de l'ophtalmologie au Brésil. Plus de détails

FLRY3 analyse fondamentale
Score flocon de neige
Évaluation5/6
Croissance future2/6
Performances passées5/6
Santé financière4/6
Dividendes4/6

Récompenses

Se négocie à 36.3% en dessous de notre estimation de sa juste valeur

Les bénéfices devraient augmenter 13.82% par an

Les bénéfices ont augmenté de 64.3% au cours de l'année écoulée

Les analystes s'accordent à dire que le prix des actions augmentera de 41%

Analyse des risques

Historique instable des dividendes


Fleury S.A. Concurrents

Oncoclínicas do Brasil Serviços Médicos

BOVESPA:ONCO3

R$2.5b

Odontoprev

BOVESPA:ODPV3

R$5.6b

Rede D'Or São Luiz

BOVESPA:RDOR3

R$66.1b

Profarma Distribuidora de Produtos Farmacêuticos

BOVESPA:PFRM3

R$864.4m

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Fleury
Historique des cours de bourse
Prix actuel de l'actionR$13.54
Plus haut sur 52 semainesR$18.96
Plus bas sur 52 semainesR$13.46
Bêta0.60
1Variation sur 1 mois-9.25%
Variation sur 3 mois-14.52%
Variation sur 1 an-20.63%
3Variation sur 3 ans-24.01%
Variation sur 5 ans-50.06%
Évolution depuis l'introduction en bourse55.80%

Nouvelles et mises à jour récentes

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Nov 15
We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Recent updates

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Nov 15
We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 02
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Sep 26
Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Jun 18
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Apr 16
The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Mar 14
Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Jan 05
Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Oct 05
Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Jun 27
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Feb 25
We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Sep 26
At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Sep 08
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

Jul 01
Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Jun 10
When Should You Buy Fleury S.A. (BVMF:FLRY3)?

Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Apr 10
Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

Mar 24
Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Feb 08
At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Dec 08
Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Nov 05
Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Oct 21
Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Aug 24
Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Jul 31
Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Jul 07
Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Apr 30
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

Apr 12
Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Mar 29
At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Mar 16
Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Mar 01
Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 28
Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Feb 15
What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Feb 02
Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return

Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Jan 03
Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date

Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Dec 28
Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?

Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Dec 12
Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?

Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Nov 29
Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE

Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Aug 30
Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult

Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Aug 18
Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield

Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Aug 03
Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?

Rendement pour les actionnaires

FLRY3BR HealthcareBR Marché
7D-3.0%0.3%-0.06%
1Y-20.6%-13.6%-1.6%

Rendement vs Industrie: FLRY3 a sous-performé le secteur BR Healthcare qui a rapporté -13.6 % au cours de l'année écoulée.

Rendement vs marché: FLRY3 a sous-performé le marché BR qui a rapporté -1.6 % au cours de l'année écoulée.

Volatilité des prix

Is FLRY3's price volatile compared to industry and market?
FLRY3 volatility
FLRY3 Average Weekly Movement3.1%
Healthcare Industry Average Movement6.1%
Market Average Movement4.5%
10% most volatile stocks in BR Market8.5%
10% least volatile stocks in BR Market2.3%

Cours de l'action stable: FLRY3 n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de FLRY3 ( 3% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
192627,000Jeane Tsutsuiri.fleury.com.br

Fleury S.A., avec ses filiales, fournit des services médicaux dans les domaines du diagnostic, du traitement, de l'analyse clinique, de la gestion de la santé, des soins médicaux, de l'orthopédie et de l'ophtalmologie au Brésil. L'entreprise opère à travers trois segments : Médecine diagnostique, Médecine intégrée et Soins dentaires. Elle propose des tests de laboratoire et d'imagerie, des services de génomique, de gestion de la santé et de plateforme, des informations de diagnostic, des bilans de santé et des laboratoires de référence, des cliniques de jour, des centres de perfusion, des services d'orthopédie et d'ophtalmologie, des tests d'imagerie dentaire et des services d'imagerie diagnostique.

Fleury S.A. Résumé des fondamentaux

Comment les bénéfices et les revenus de Fleury se comparent-ils à sa capitalisation boursière ?
FLRY3 statistiques fondamentales
Capitalisation boursièreR$7.49b
Bénéfices(TTM)R$613.53m
Recettes(TTM)R$7.55b

12.0x

Ratio P/E

1.0x

Ratio P/S

Le site FLRY3 est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
FLRY3 compte de résultat (TTM)
RecettesR$7.55b
Coût des recettesR$5.46b
Marge bruteR$2.09b
Autres dépensesR$1.48b
Les revenusR$613.53m

Derniers bénéfices déclarés

Sep 30, 2024

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)1.13
Marge brute27.69%
Marge bénéficiaire nette8.13%
Ratio dettes/capitaux propres71.2%

Quelles ont été les performances à long terme de FLRY3?

Voir les performances historiques et les comparaisons

Dividendes

4.3%

Rendement actuel des dividendes

13%

Ratio de distribution